Alisa Klepach joined the Dann Lab in 2015, working with Sundhar Subramanian on c-di-GMP signaling pathways in Gram-positive bacterial models up through her undergraduate graduation in 2016. She graduated with Bachelors degrees in Biochemistry and French, then went on to work at Eli Lilly in the Biotechnology Discovery Research group (BioTDR) on oral formulation technology for therapeutic peptides. She now works in Pharmaceutical Project Mgmt. (PPM) at Lilly on late-phase diabetes assets.
The College of Arts